Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZFP36L1 (mRNA decay activator protein ZFP36L1) is an RNA-binding protein belonging to the ZFP36 (TTP/TIS11) family, characterized by two CCCH-type zinc finger motifs. It regulates gene expression post-transcriptionally by binding AU-rich elements (AREs) in the 3′ untranslated region of target mRNAs, recruiting cellular decay enzymes (CCR4-NOT deadenylase, decapping enzymes DCP1/DCP2, exoribonucleases XRN1, and the exosome) for mRNA destabilization and degradation. ZFP36L1 serves roles in inflammation, antiviral defense (notably against influenza A, JEV, and DENV), angiogenesis, cancer suppression, B cell and thymic development, and muscle differentiation. Its antiviral activity is mechanistically linked to binding and destabilizing viral RNAs, and translational repression of select viral proteins. Dysregulation or mutation of ZFP36L1 can contribute to pathogenesis in numerous diseases.
Drugs or gene interventions targeting ZFP36L1 would be expected to modulate gene expression via: - Enhancement or inhibition of ARE-mediated mRNA decay - Translational repression of target mRNAs - Modulation of antiviral activity by affecting ZFP36L1's RNA-binding function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on mRNA decay activator protein ZFP36L1 (ZFP36L1).